← Open Payments lookup

JENNA HEFEL: Open Payments

NPI 1770153058 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$280 in 16 payments from 10 companies in 2025. Trend: 2023 $403 · 2024 $523 · 2025 $280

Food & beverage: $280
CompanyPaymentsAmount
ABBVIE INC.4$65
Teva Pharmaceuticals USA, Inc.2$38
Neurocrine BioSciences, Inc.2$35
Alkermes, Inc.2$33
Supernus Pharmaceuticals, Inc.1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
Otsuka America Pharmaceutical, Inc.1$19
Axsome Therapeutics, Inc.1$16
ACADIA Pharmaceuticals Inc1$15
E.R. Squibb & Sons, L.L.C.1$14

Products named: VRAYLAR, INGREZZA, Qelbree, CAPLYTA, AUSTEDO XR, REXULTI, ARISTADA, UZEDY.

Industry payments across IA — which companies pay providers there.